These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 51012)

  • 1. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
    Blasecki JW; Tevethia SS
    Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
    Law LW; Takemoto KK; Rogers MJ; Ting RC
    J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S; Huet C; Tournier P
    Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40.
    Tevethia SS; Tevethia MJ
    Prog Med Virol; 1975; 21():103-17. PubMed ID: 174151
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells.
    Rogers MJ; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1291-5. PubMed ID: 198559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
    Henriksen O; Law LW; Appella E
    J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of SV40-related transplantation immunity in mice by BK virus-transformed cells.
    Kato K; Iwamura Y; Kurimura T
    Jpn J Med Sci Biol; 1979 Oct; 32(5):311-4. PubMed ID: 94612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). II. Association of SV40-TSTA activity with liposomes containing VSV glycolipids.
    Huet C; Ansel S
    Int J Cancer; 1977 Jul; 20(1):61-6. PubMed ID: 71275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific transplantation antigen: use of the Ad2+ND1 hybrid virus to identify the protein responsible for simian virus 40 tumor rejection and its genetic origin.
    Jay G; Jay FT; Chang C; Friedman RM; Levine AS
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3055-9. PubMed ID: 80009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SV40 transplantation antigen: relationship to SV40-specific proteins.
    Tevethia SS; Greenfield RS; Flyer DC; Tevethia MJ
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():235-42. PubMed ID: 6253137
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells.
    Chang C; Martin RG; Livingston DM; Luborsky SW; Hu CP; Mora PT
    J Virol; 1979 Jan; 29(1):69-75. PubMed ID: 219235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
    Ting CC; Rodrigues D; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.